Goeijenbier M, Van Wissen M, van de Weg C, Jong E, Gerdes VE, Meijers JC, Brandjes DP, van Gorp EC: Review: Viral infections and mechanisms of thrombosis and bleeding. J Med Virol 2012, 84:1680–1696.PubMedCrossRef 9. Berri F, Le VB, Jandrot-Perrus M, Lina B, Riteau B: Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits. Cell Mol Life Sci 2014, 71:885–898.PubMedCrossRef 10. Bazaz R, Marriott HM, Francis SE, Dockrell DH: Mechanistic links between acute respiratory tract infections and acute coronary syndromes.
J Infect 2013, 66:1–17.PubMedCrossRef 11. Antoniak S, Mackman N: Multiple roles of the coagulation protease cascade during virus infection. Blood 2014, 123:2605–2613.PubMedCrossRef 12. Perez-Padilla R, De La R-Z, Ponce De Leon S, Hernandez M, Quinones-Falconi Lazertinib F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, Higuera A, Mondragon E, Cordova-Villalobos JA, INER Osimertinib Working Group on Influenza: Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680–689.PubMedCrossRef 13. Ohrui T, Takahashi H, Ebihara S, Matsui T, Nakayama K, Sasaki H: Influenza A virus infection and pulmonary microthromboembolism. Tohoku J Exp Med 2000, 192:81–86.PubMedCrossRef 14. Wang ZF, Su F, Lin XJ, Dai B, Kong LF, Zhao HW, Kang J: Serum D-dimer changes and prognostic implication in 2009 novel influenza A(H1N1). Thromb
Res 2011, 127:198–201.PubMedCrossRef 15. Keller TT, van der Sluijs KF, De Kruif M, Gerdes VE, Meijers JC, Florquin S, van der Poll T, van Gorp EC, Brandjes
DP, Büller HR, Levi M: Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated GS-9973 mw protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res 2006, 99:1261–1269.PubMedCrossRef 16. (-)-p-Bromotetramisole Oxalate Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B: PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 2013, 123:206–214.PubMedCentralPubMedCrossRef 17. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, Barman S, Webster RG, Webby RJ: Adaptation of pandemic H1N1 influenza viruses in mice. J Virol 2010, 84:8607–8616.PubMedCentralPubMedCrossRef 18. van den Brand JM, Stittelaar KJ, Leijten LM, Van Amerongen G, Simon JH, Osterhaus AD, Kuiken T: Modification of the ferret model for pneumonia from seasonal human influenza A virus infection. Vet Pathol 2012, 49:562–568.PubMedCrossRef 19. Stark GV, Long JP, Ortiz DI, Gainey M, Carper BA, Feng J, Bigger JE, Vela EM: Clinical profiles associated with influenza disease in the ferret model. PLoS One 2013, 8:e58337.PubMedCentralPubMedCrossRef 20. Lichenstein R, Magder LS, King RE, King JC Jr: The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period.